Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Physics in Medicine and Biology

• Publication date

  1994-11-01

• Fields of study

  Medicine, Physics, Mathematics

• Identifiers
  DOI 10.1088/0031-9155/52/1/019PMID 17183142
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On cold spots in tumor subvolumes.

  2002cited by this paper
• Log-normal Distributions across the Sciences: Keys and Clues

  2001cited by this paper
• Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans.

  2001cited by this paper
• Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy.

  2001cited by this paper
• Reporting and analyzing dose distributions: a concept of equivalent uniform dose.

  1997cited by this paper
• Optimum parameters in a model for tumour control probability including interpatient heterogeneity.

  1995cited by this paper
• Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation.

  1993cited by this paper
• Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation.

  1993cited by this paper
• Dose, volume, and tumor-control predictions in radiotherapy.

  1993cited by this paper
• The effect on tumour control probability of varying the setting of a multileaf collimator with respect to the planning target volume.

  1993cited by this paper
• Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

  1993cited by this paper
• A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

  1993cited by this paper
• The Physics of Three Dimensional Radiation Therapy: Conformal Radiotherapy, Radiosurgery and Treatment Planning

  1993cited by this paper
• Clinical implications of heterogeneity of tumor response to radiation therapy.

  1992cited by this paper
• Steepness of the Clinical Dose–control Curve and Variation in the in Vitro Radiosensitivity of Head and Neck Squamous Cell Carcinoma

  1992cited by this paper
• Maximizing Local Control by Customized Dose Prescription for Pelvic Tumours

  1992cited by this paper
• Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma.

  1992cited by this paper
• Optimization by simulated annealing of three-dimensional, conformal treatment planning for radiation fields defined by a multileaf collimator: II. Inclusion of two-dimensional modulation of the x-ray intensity.

  1992cited by this paper
• Fitting of normal tissue tolerance data to an analytic function.

  1991cited by this paper
• Analysis of early and lats deaths on RTOG non-small cell lung carcinoma trials vs. CALGB 8433

  1991cited by this paper
• Tolerance of normal tissue to therapeutic irradiation.

  1991cited by this paper
• Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture.

  1991cited by this paper
• Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

  1991cited by this paper
• Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma?

  1990cited by this paper
• How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics?

  1990cited by this paper
• Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

  1989cited by this paper
• Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm.

  1989cited by this paper
• An approach to the interpretation of clinical data on the tumour control probability-dose relationship.

  1988cited by this paper
• The dose-rate effect in human tumour cells.

  1987cited by this paper
• The relationship of dose to infield failure for stages A, B and C prostate cancer. An analysis of 1516 patients

  1987cited by this paper
• Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms.

  1987cited by this paper
• Some factors of importance in the radiation treatment of malignant melanoma.

  1986cited by this paper
• Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy. Analysis of neck disease response in 1646 cases.

  1986cited by this paper
• Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital.

  1985cited by this paper
• Complication Probability as Assessed from Dose-Volume Histograms

  1985cited by this paper
• Dosimetric precision requirements in radiation therapy.

  1984cited by this paper
• The interplay of radiocurability and tolerance in the irradiation of human cancers.

  1975cited by this paper
• The interplay of radiocurability and tolerance in the irradiation of human cancers.

  1975cited by this paper
• The logarithm in biology. II. Distributions simulating the log-normal.

  1969cited by this paper
• The logarithm in biology. 1. Mechanisms generating the log-normal distribution exactly.

  1966cited by this paper

• Realistic closed-form TCP model including cell sensitivity dependence

  2025cites this paper
• Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient‐specific or population‐based biological features

  2024cites this paper
• AAPM Task Group Report 267: A joint AAPM GEC‐ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy

  2024cites this paper
• Modeling of the resensitization effect on carbon-ion radiotherapy for stage I non-small cell lung cancer

  2024cites this paper
• Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

  2024cites this paper
• Patient-specific voxel-level dose prescription for prostate cancer radiotherapy considering tumour cell density and grade distribution.

  2023cites this paper
• Mathematical modelling of the distribution of tumor size in patient populations

  2023cites this paper
• Practical parameter identifiability and handling of censored data with Bayesian inference in mathematical tumour models

  2023cites this paper
• Quantification of the uncertainties within the radiotherapy dosimetry chain and their impact on tumour control

  2021cites this paper
• The influence of Acuros XB on dose volume histogram metrics and tumour control probability modelling in locally advanced non-small cell lung cancer.

  2020cites this paper
• Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI

  2020cites this paper
• Dose volume histogram metrics and tumour control probability modelling in locally advanced non-small-cell lung cancer: average intensity dataset versus individual four-dimensional CT phases

  2020cites this paper
• Radiation dose intensity and local tumour control of non-small cell lung cancer: A radiobiological modelling perspective

  2019cites this paper
• Kinetic modeling of tumor regression incorporating the concept of cancer stem-like cells for patients with locally advanced lung cancer

  2018cites this paper
• Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy

  2018cites this paper
• An evaluation method of clinical impact with setup, range, and radiosensitivity uncertainties in fractionated carbon-ion therapy

  2018cites this paper
• Optimization of Radiation Dosing Schedules

  2017cites this paper
• Prognostic Modeling and Analysis of Tumor Response to Fractionated Radiotherapy for Patients with Squamous Cell Lung Cancer

  2017cites this paper
• Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.

  2017cites this paper
• The potential for increased tumor control probability in non-small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume.

  2017cites this paper
• Coupling I‐125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models

  2017cites this paper
• PET-basert doseintensivering og adaptiv stråleterapi av analkreft

  2017influential citation
• Adaptive modelling of tumour volume dynamics under radiotherapy

  2016cites this paper
• Radiobiological Principles Underlying Stereotactic Radiation Therapy

  2015cites this paper
• Robust Optimization for Uncertain Radiobiological Parameters in Inverse Dose Planning

  2015cites this paper
• High-dose and fractionation effects in stereotactic radiation therapy: Analysis of tumor control data from 2965 patients.

  2015cites this paper
• Postoperative radiotherapy following mastectomy for patients with left-sided breast cancer: A comparative dosimetric study.

  2015cites this paper
• 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.

  2014cites this paper
• A simulation framework for modeling tumor control probability in breast conserving therapy.

  2014cites this paper
• Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose

  2014cites this paper
• Utilitarian prioritization of radiation oncology patients based on maximization of population tumour control

  2013cites this paper
• Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment

  2012cites this paper
• In Silico Modelling of Treatment-Induced Tumour Cell Kill: Developments and Advances

  2012cites this paper
• Comp Plan: A computer program to generate dose and radiobiological metrics from dose-volume histogram files.

  2012cites this paper
• Impact of negative margin width on local recurrence in breast conserving therapy.

  2012cites this paper
• State-based simulations of tumor response to radiotherapy

  2012cites this paper
• Population TCP estimators in case of heterogeneous irradiation: A new discussion of an old problem

  2010cites this paper
• Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy.

  2010cites this paper
• The role of protons in modern and biologically-guided radiotherapy

  2010cites this paper
• Mathematical optimization in intensity modulated radiation therapy

  2010cites this paper
• Adaptive Radiation Therapy Of Prostate Cancer

  2010cites this paper
• Fundamental Radiobiology and its Application to Radiation Oncology

  2009cites this paper
• Treatment of stage III non-small cell lung cancer and limited-disease small-cell lung cancer

  2009cites this paper
• Optimal Treatment Planning in Radiotherapy Based on Boltzmann Transport Equations

  2008cites this paper
• Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects

  2008cites this paper
• Estimate of radiobiologic parameters from clinical data for biologically based treatment planning for liver irradiation.

  2008cites this paper
• Convex reformulation of biologically-based multi-criteria IMRT optimisation including fractionation effects

  2008cites this paper
• Time-dependent cell disintegration kinetics in lung tumors after irradiation

  2008cites this paper
• Radiotherapy treatment delays and their influence on tumour control achieved by various fractionation schedules.

  2008cites this paper
• Mathematical optimization in intensity modulated radiation therapy

  2008cites this paper
• Modeling Outcome After Prostate IGRT

  2008cites this paper
• Self-consistent tumor control probability and normal tissue complication probability models based on generalized EUDa).

  2007cites this paper
• Optimization of HDR Brachytherapy Treatment Plans

  2007cites this paper
• Fundamental form of a population TCP model in the limit of large heterogeneity.

  2006cites this paper
• A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.

  2006cites this paper
• Tumour control and normal tissue complication probabilities: can they be correlated with the measured clinical outcomes of prostate cancer radiotherapy?

  2005cites this paper
• Limitations of a TCP model incorporating population heterogeneity

  2005cites this paper
• Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: in regard to D'Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540-1548).

  2005cites this paper